Review article · 2024 · Open access

NF-κB in biology and targeted therapy: new insights and translational implications

Qing Guo, Yizi Jin, Xinyu Chen, Xiaomin Ye, Xin Shen, Mingxi Lin, Cheng Zeng, Teng Zhou, Jian Zhang

Signal Transduction and Targeted Therapy, 9(1), 53 · Published 3 March 2024 · DOI 10.1038/s41392-024-01757-9

Free PDFView at the publisherCite this paper

In brief

“NF-κB in biology and targeted therapy: new insights and translational implications” is a 2024 review article by Qing Guo and 8 co-authors, published in Signal Transduction and Targeted Therapy. OpenAlex counts 2,470 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Signal Transduction and Targeted Therapy.

Citations
2,470
Most cited in
2026 (1,148)
Field-weighted impact
91.62
References
622
Authors
9

Abstract

NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was identified as a pivotal pathway in mediating inflammatory responses. However, with extensive and in-depth investigations, researchers have discovered that its role can be expanded to a variety of signaling mechanisms, biological processes, human diseases, and treatment options. In this review, we first scrutinize the research process of NF-κB signaling, and summarize the composition, activation, and regulatory mechanism of NF-κB signaling. We investigate the interaction of NF-κB signaling with other important pathways, including PI3K/AKT, MAPK, JAK-STAT, TGF-β, Wnt, Notch, Hedgehog, and TLR signaling. The physiological and pathological states of NF-κB signaling, as well as its intricate involvement in inflammation, immune regulation, and tumor microenvironment, are also explicated. Additionally, we illustrate how NF-κB signaling is involved in a variety of human diseases, including cancers, inflammatory and autoimmune diseases, cardiovascular diseases, metabolic diseases, neurological diseases, and COVID-19. Further, we discuss the therapeutic approaches targeting NF-κB signaling, including IKK inhibitors, monoclonal antibodies, proteasome inhibitors, nuclear translocation inhibitors, DNA binding inhibitors, TKIs, non-coding RNAs, immunotherapy, and CAR-T. Finally, we provide an outlook for research in the field of NF-κB signaling. We hope to present a stereoscopic, comprehensive NF-κB signaling that will inform future research and clinical practice.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024). NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduction and Targeted Therapy, 9(1), 53. https://doi.org/10.1038/s41392-024-01757-9

MLA 9

Guo, Qing, et al. “NF-κB in biology and targeted therapy: new insights and translational implications.” Signal Transduction and Targeted Therapy, vol. 9, no. 1, 2024, p. 53. https://doi.org/10.1038/s41392-024-01757-9.

Chicago

Guo, Qing, Yizi Jin, Xinyu Chen, Xiaomin Ye, Xin Shen, Mingxi Lin, Cheng Zeng, Teng Zhou, and Jian Zhang. 2024. “NF-κB in biology and targeted therapy: new insights and translational implications.” Signal Transduction and Targeted Therapy 9 (1): 53. https://doi.org/10.1038/s41392-024-01757-9.

Harvard

Guo, Q. et al. (2024) ‘NF-κB in biology and targeted therapy: new insights and translational implications’, Signal Transduction and Targeted Therapy, 9(1), p. 53. doi:10.1038/s41392-024-01757-9.

IEEE

Q. Guo et al., “NF-κB in biology and targeted therapy: new insights and translational implications,” Signal Transduction and Targeted Therapy, vol. 9, no. 1, p. 53, 2024, doi: 10.1038/s41392-024-01757-9.

BibTeX

@article{guo2024biology,
  title     = {{NF-κB in biology and targeted therapy: new insights and translational implications}},
  author    = {Guo, Qing and Jin, Yizi and Chen, Xinyu and Ye, Xiaomin and Shen, Xin and Lin, Mingxi and Zeng, Cheng and Zhou, Teng and Zhang, Jian},
  journal   = {Signal Transduction and Targeted Therapy},
  year      = {2024},
  volume    = {9},
  number    = {1},
  pages     = {53},
  doi       = {10.1038/s41392-024-01757-9},
  url       = {https://doi.org/10.1038/s41392-024-01757-9}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
2024239239
20251,0821082
20261,1481148

Its field-weighted citation impact is 91.62: it has been cited 91.62 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways

  • NF-κB signaling
  • NF-κB activation
  • NF-κB regulation
  • PI3K/Akt signaling
  • MAPK signaling
  • JAK/STAT signaling
  • TGF-beta signaling
  • Wnt signaling

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024). NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduction and Targeted Therapy, 9(1), 53. https://doi.org/10.1038/s41392-024-01757-9

How many times has this paper been cited?

2,470 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Signal Transduction and Targeted Therapy.

Who wrote this paper?

Qing Guo, Yizi Jin, Xinyu Chen, Xiaomin Ye, Xin Shen, Mingxi Lin, Cheng Zeng, Teng Zhou, Jian Zhang.

What is the DOI of this paper?

10.1038/s41392-024-01757-9. The permanent link is https://doi.org/10.1038/s41392-024-01757-9.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.